The question is who stands to gain most from the tax policymaking in Washington — corporations, their shareholders and their executives, most of whom don’t have to worry about whether cutting off Obamacare subsidies will leave them unable to afford healthcare, or the millions of Americans for whom the subsidies can often spell the difference between life and death?
Quoted Staff Member